« horizontal w-t-w versus capsular bag size | Main | Risk factors for perforation in microbial corneal ulcers in north India »
May 21, 2006
Bausch & Lomb acquires license to patent retinal disease treatment
Eyeworld weekly news
drug SurModics (Eden Prairie, Minn.) announced it granted Bausch & Lomb (Rochester, N.Y.) an exclusive license to patents relating to the use of Genistein in the treatment and prevention of retinal diseases, according to a SurModics news release. Genistein is a soy isoflavone with anti-oxidant and anti-vascular endothelial growth factor (VEGF) activity that has been shown to reduce retinal vascular leakage in diabetic animals
Posted by mehdi khanlari at May 21, 2006 11:51 PM